By Matthew Perlman ( March 23, 2023, 9:36 PM EDT) -- Federal Trade Commission staffers pushed back against Illumina's contentions that enforcers improperly coordinated with overseas counterparts to try to derail its deal for cancer-testing outfit Grail Inc., saying the company wants to distract from the merits of the commission's challenge....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.